About Glenmark Life Sciences
Glenmark Life Sciences is a company based in Mumbai (India) founded in 2011 was acquired by Nirma in September 2023. The company has 3,940 employees as of March 31, 2024. Glenmark Life Sciences offers products and services including Active Pharmaceutical Ingredients and CDMO Services. Glenmark Life Sciences operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- Employees 3940 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alivus Life Sciences Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Glenmark Life Sciences
Glenmark Life Sciences is a publicly listed company on the NSE with ticker symbol ALIVUS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Glenmark Life Sciences
Glenmark Life Sciences offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and CDMO Services.
Develops high-quality APIs for chronic disease treatments globally.
Provides end-to-end support for API and intermediate manufacturing.
People of Glenmark Life Sciences
Unlock access to complete
Funding Insights of Glenmark Life Sciences
Investors in Glenmark Life Sciences
Investments & Acquisitions by Glenmark Life Sciences
Financial Statements - Glenmark Life Sciences
Glenmark Life Sciences Comparisons
Competitors of Glenmark Life Sciences
Glenmark Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Latest news on Glenmark Life Sciences
Frequently Asked Questions about Glenmark Life Sciences
Glenmark Life Sciences was founded in 2011.
Glenmark Life Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Yasir Rawjee is the current CEO of Glenmark Life Sciences.
As of Mar 31, 2024, the latest employee count at Glenmark Life Sciences is 3,940.
Annual revenue of Glenmark Life Sciences is $277.1M as on Mar 31, 2024.
Glenmark Life Sciences was founded in 2011 and is headquartered in Mumbai, India. Operations are centered on contract development and manufacturing organization (CDMO) services for active pharmaceutical ingredients (APIs). The company supports pharmaceutical production through API synthesis and supply, serving global clients in the healthcare sector. Leadership is provided by Yasir Rawjee as CEO and Managing Director.
Glenmark Life Sciences's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Glenmark Life Sciences offers Active Pharmaceutical Ingredients and CDMO Services.
Yes, Glenmark Life Sciences is publicly traded on NSE under the ticker symbol ALIVUS.
Glenmark Life Sciences has 1 investor. Key investors include Nirma.
The ticker symbol of Glenmark Life Sciences is ALIVUS on NSE.